Advancing Clinical Trial Design to Accommodate Biological & Clinical Heterogeneity Underlying Alzheimer’s Pathology
Time: 11:00 am
day: Conference Day One - Track Three
Details:
- Overcoming challenges of Alzheimer’s heterogeneity in clinical trials
- Adapting trial designs to enable a more personalized approach
- Showcasing examples of advances in repeatable biomarkers and digital phenotyping
